SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-200958"
 

Search: onr:"swepub:oai:DiVA.org:liu-200958" > Integration of impl...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00007824naa a2200949 4500
001oai:DiVA.org:liu-200958
003SwePub
008240221s2024 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:238269474
009oai:prod.swepub.kib.ki.se:154800111
024a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-2009582 URI
024a https://doi.org/10.1002/ejhf.31502 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:2382694742 URI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1548001112 URI
040 a (SwePub)liud (SwePub)kid (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Mullens, Wilfriedu Ziekenhuis Oost Limburg, Belgium; UHasselt, Belgium; Ziekenhuis Oost Limburg, Belgium4 aut
2451 0a Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)
264 c 2024
264 1b WILEY,c 2024
338 a print2 rdacarrier
520 a Implantable devices form an integral part of the management of patients with heart failure (HF) and provide adjunctive therapies in addition to cornerstone drug treatment. Although the number of these devices is growing, only few are supported by robust evidence. Current devices aim to improve haemodynamics, improve reverse remodelling, or provide electrical therapy. A number of these devices have guideline recommendations and some have been shown to improve outcomes such as cardiac resynchronization therapy, implantable cardioverter-defibrillators and long-term mechanical support. For others, more evidence is still needed before large-scale implementation can be strongly advised. Of note, devices and drugs can work synergistically in HF as improved disease control with devices can allow for further optimization of drug therapy. Therefore, some devices might already be considered early in the disease trajectory of HF patients, while others might only be reserved for advanced HF. As such, device therapy should be integrated into HF care programmes. Unfortunately, implementation of devices, including those with the greatest evidence, in clinical care pathways is still suboptimal. This clinical consensus document of the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) describes the physiological rationale behind device-provided therapy and also device-guided management, offers an overview of current implantable device options recommended by the guidelines and proposes a new integrated model of device therapy as a part of HF care.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
653 a Heart failure; Device therapy
700a Dauw, Jeroenu Ziekenhuis Oost Limburg, Belgium; UHasselt, Belgium4 aut
700a Gustafsson, Finnu Univ Hosp Copenhagen, Denmark4 aut
700a Mebazaa, Alexandreu Univ Paris, France; St Louis Lariboisiere Univ Hosp, France4 aut
700a Steffel, Janu Hirslanden Heart Clin, Switzerland; Univ Zurich, Switzerland,Univ Warwick, England4 aut
700a Witte, Klaus K.u Rhein Westfal TH Aachen, Germany4 aut
700a Delgado, Victoriau Leiden Univ, Netherlands; Hosp Univ Germans Trias i Pujol, Spain4 aut
700a Linde, Ceciliau Karolinska Institutet,Karolinska Univ Hosp, Sweden4 aut
700a Vernooy, Kevinu Maastricht Univ Med Ctr MUMC, Netherlands4 aut
700a Anker, Stefan D.u Charite Univ Med Berlin, Germany; Charite Univ Med Berlin, Germany4 aut
700a Chioncel, Ovidiuu Univ Med & Pharm Carol Davila, Romania4 aut
700a Milicic, Davoru Univ Zagreb, Croatia4 aut
700a Hasenfuss, Gerdu Univ Med Ctr Gottingen UMG, Germany4 aut
700a Ponikowski, Piotru Wroclaw Med Univ, Poland4 aut
700a Stephan von Bardeleben, Ralphu Univ Med Ctr Mainz, Germany4 aut
700a Koehler, Friedrichu Charite Univ Med Berlin, Germany4 aut
700a Ruschitzka, Franku Univ Hosp Zurich, Switzerland4 aut
700a Damman, Kevinu Univ Groningen, Netherlands4 aut
700a Schwammenthal, Ehudu Sheba Med Ctr, Israel; Tel Aviv Univ, Israel4 aut
700a Testani, Jeffrey M.u Yale Sch Med, CT USA,Univ Brescia, Italy; Univ Brescia, Italy4 aut
700a Zannad, Faiezu Univ Lorraine, France4 aut
700a Boehm, Michaelu Saarland Univ, Germany4 aut
700a Cowie, Martin R.u Kings Coll London, England; Kings Coll London, England,St Georges Univ, England4 aut
700a Dickstein, Kennethu Univ Bergen, Norway; Stavanger Univ Hosp, Norway4 aut
700a Jaarsma, Tinyu Linköpings universitet,Avdelningen för omvårdnad och reproduktiv hälsa,Medicinska fakulteten,Univ Med Ctr Utrecht, Netherlands; Australian Catholic Univ, Australia4 aut0 (Swepub:liu)tinja77
700a Filippatos, Gerasimosu Natl & Kapodistrian Univ Athens, Greece4 aut
700a Volterrani, Mauriziou IRCCS San Raffaele, Italy4 aut
700a Thum, Thomasu Hannover Med Sch, Germany; Fraunhofer Inst Toxicol & Expt Med, Germany4 aut
700a Adamopoulos, Stamatisu Onassis Cardiac Surg Ctr, Greece4 aut
700a Cohen-Solal, Alainu Univ Hosp Lariboisiere, France; Univ Paris Cite, France4 aut
700a Moura, Brendau Armed Forces Hosp, Portugal; Fac Med Porto, Portugal4 aut
700a Rakisheva, Aminau Sci Inst Cardiol & Internal Med, Kazakhstan4 aut
700a Ristic, Arsenu Univ Belgrade, Serbia; Serbian Acad Arts & Sci, Serbia4 aut
700a Bayes-Genis, Antoniu Hosp Univ Germans Trias i Pujol, Spain4 aut
700a Van Linthout, Sophieu Charite Univ Med Berlin, Germany; German Ctr Cardiovasc Res DZHK, Germany4 aut
700a Tocchetti, Carlo Gabrieleu Dept Translat Med Sci DISMET, Italy; Interdept Hypertens Res Ctr CIRIAPA, Italy; Univ Naples Federico II, Italy4 aut
700a Savarese, Gianluigiu Karolinska Institutet,Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden4 aut
700a Skouri, Hadiu Amer Univ Beirut, Lebanon4 aut
700a Adamo, Mariannau Univ Brescia, Italy; Univ Brescia, Italy4 aut
700a Amir, Offeru Hebrew Univ Jerusalem, Israel4 aut
700a Yilmaz, Mehmet Birhanu Dokuz Eylul Univ, Turkiye4 aut
700a Simpson, Maggieu NHS Greater Glasgow & Clyde, Scotland4 aut
700a Tokmakova, Mariyau Med Univ Plovdiv, Bulgaria4 aut
700a Gonzalez, Arantxau CIMA Univ Navarra, Spain; Navarra Inst Hlth Res, Spain; Carlos III Inst Hlth, Spain4 aut
700a Piepoli, Massimou Univ Milan, Italy4 aut
700a Seferovic, Petaru Univ Belgrade, Serbia; Serbian Acad Arts & Sci, Serbia4 aut
700a Metra, Marcou Univ Brescia, Italy; Univ Brescia, Italy4 aut
700a Coats, Andrew J. S.u Univ Warwick, England4 aut
700a Rosano, Giuseppe M. C.u St Georges Univ, England4 aut
710a Ziekenhuis Oost Limburg, Belgium; UHasselt, Belgium; Ziekenhuis Oost Limburg, Belgiumb Ziekenhuis Oost Limburg, Belgium; UHasselt, Belgium4 org
773t European Journal of Heart Failured : WILEYx 1388-9842x 1879-0844
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-200958
8564 8u https://doi.org/10.1002/ejhf.3150
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:238269474
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:154800111

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view